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Abstract
Background: Research is scarce with regard to the role of psychotic and schizotypal symptoms in treatment of
obsessive-compulsive disorder (OCD). The aim of the current study was to investigate the occurrence and specificity
of psychotic and schizotypal symptoms among non-psychotic OCD patients, and to examine whether such symptoms
was associated with response to exposure and response prevention (ERP), and whether ERP for OCD had an impact on
psychotic and schizotypal symptoms.
Methods: Non-psychotic OCD patients (n = 133) and a general non-psychotic psychiatric outpatient sample (n = 110)
were assessed using self-report inventories before and after psychological treatment.
Results: Non-psychotic OCD patients did not report greater degree of psychotic or schizotypal symptoms than the
control group. Psychotic and schizotypal symptoms were not associated with OCD symptoms before or after ERP.
Psychotic and schizotypal symptom were significantly reduced following ERP.
Conclusions: Psychotic and schizotypal symptoms seem to be equally prevalent among non-psychotic OCD
patients and non-psychotic psychiatric controls. These symptoms were more linked to depressive symptoms than
OCD symptoms. In non-psychotic OCD patients, ERP seems sufficient in reducing OCD symptoms despite the
presence of psychotic- and schizotypal symptoms, and reductions in psychotic- and schizotypal symptoms were
observed following ERP.
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Background
Obsessive-compulsive disorder (OCD) and psychotic
disorders exhibit both biological and phenomenological
overlap [1]. Furthermore, there might not be a clear dis-
tinction in OCD between delusions and obsessions as
OCD patients describe varying degrees of overvalued
ideas [2]. Studies also indicate that obsessions can trans-
form into delusions [3], and that OCD and symptoms of
OCD can be associated with the development of psych-
otic disorder over time [4]. An increased prevalence of
OCD in patients with first-episode psychosis has also
been found [5]. Although this may seem to link OCD
and psychotic symptoms, other studies show mixed evi-
dence concerning this relation, leaving unanswered the
question of whether psychotic and schizotypal symptoms
are particularly associated with OCD, or whether they
constitute symptoms that are just as prevalent in several
other emotional disorders.
Some studies have explored psychotic symptoms in
patients with OCD [4, 6–10]. It has been argued that a
symptom-based approach may be more favourable than
a diagnostic approach due to questionable validity of
diagnostic systems, substantial variation in symptomatol-
ogy within categorical diagnosis and the ignoring of
likely continua in the symptomatology between normal
and pathological [11]. However, there is great variety in
the reported occurrence of such symptoms, ranging
from zero to fifty percent [4].
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There have been proposals of a distinct subtype of
schizotypal OCD [3, 6, 12], as OCD patients with schizo-
typal symptoms have poorer insight and lower function-
ing than OCD patients without such symptoms.
However, there are discrepant findings. One study found
that patients with depression, panic disorder, social pho-
bia, post-traumatic stress disorder, or alcohol/substance
dependency, had higher life-time prevalence of schizo-
typal personality disorder than patients with OCD [7]. A
second study found that patients with OCD reported
more symptoms of schizotypal disorder than patients
with depression, but less so than patients with bipolar
disorder or schizophrenia [13]. A third study found
that OCD patients with schizotypal symptoms reported
higher rates of comorbid major depression, post-
traumatic stress disorder, substance use disorders, and
greater general psychopathology [14]. They did not
find any associations between schizotypal symptoms
and OCD when controlling for differences in demo-
graphics and comorbidity.
To further complicate matters, a longitudinal study
argued that sub-clinical levels of psychotic disorders
are associated with development of anxiety, emotional
and substance-related disorders [15]. Unlike the studies
mentioned above, this study indicated that such an as-
sociation was stronger between OCD and psychotic
symptoms, than any of the other disorders. The pro-
posed association between symptoms of OCD and
psychotic and schizotypal symptoms may also be mod-
erated by symptom severity [16] because low levels of
schizotypal and OCD symptoms were distinct from
each other, whereas among high scoring individuals the
two symptom categories were associated. Thus, it re-
mains uncertain if psychotic and schizotypal symptoms
are linked to OCD.
The presence of psychotic and schizotypal symptoms
may influence treatment outcome in OCD. Indeed, pre-
vious studies indicate that OCD patients with comorbid
schizotypal disorder show poorer response to medical
treatment for OCD [3]. Related research comes from
studies on poor insight in OCD. OCD with poor insight
has been described as egosyntonic symptoms that might
extend to delusions and psychosis [17]. Most likely, insight
falls on a continuum and is associated with symptom
severity, chronicity, and poorer treatment prognosis
[18]. There is still a great lack of knowledge with regard
to psychotic and schizotypal symptoms among patients
with OCD and how these symptoms affect psycho-
logical treatment of OCD. In addition, we do not know
whether treatment for OCD reduces psychotic and
schizotypal symptoms.
In the current study we assessed psychotic and schizo-
typal symptoms among non-psychotic patients with OCD.
Furthermore, this study aimed to elucidate whether such
symptoms are elevated in the OCD population, or simi-
larly present in a general non-psychotic psychiatric out-
patient sample. Finally, the current study aimed to
investigate whether such symptoms were associated with
reduced OCD treatment response, and if these symptoms




This study included two samples: non-psychotic patients
diagnosed with OCD (n = 133) and a general non-psychotic
psychiatric outpatient group (n = 110). Participants with
psychotic disorder, suicidal behaviour, and alcohol or
substance dependency were excluded. Before excluding
OCD patients, there were 182 treatment seekers, but
49 of these were excluded. A total of seven patients
were excluded from the OCD group due to psychotic
disorders. The number of excluded patients from the
control group is unknown. Due to missing data the
sample sizes were reduced to 103 in the non-psychotic
OCD group and 73 for the non-psychotic control group
at post-treatment.
The non-psychotic OCD group was comprised of pa-
tients from two previously published treatment studies
[19, 20], and an unpublished multi-center treatment
study. The mean age was 34.7 years (SD: 11.6) and con-
sisted of 71.5 % (n = 82) female participants. Seven pa-
tients in the non-psychotic OCD group were excluded
due to psychosis. OCD patients were diagnosed using
the Structural Clinical Interview for DSM IV Axis I Dis-
orders [21] or Anxiety Disorder Interview Schedule-
Revised [22]. Patients received either ERP-based group
therapy over a period of 12 weeks [19] or individual ERP
based on the manual by Foa [23]. A total of 65 received
group treatment and 68 had individual ERP treatment.
Independent t-tests found no significant difference be-
tween people in group and individual treatment with re-
gard to changes in symptoms of paranoia (p = .19),
psychoticism (p = .36), schizotypal signs (p = .17), and
schizophrenia nuclear signs (p = .17).
The main ingredients of ERP were in the first session to
formulate a case-conceptualization, present a habituation
rationale, and use of self-registration of rituals for home-
work. The second session involved creating the exposure
hierarchy and introducing the rules for ritual prevention.
The following sessions were similar in structure and
consisted mainly of checking homework assignments,
in vivo and imaginary exposure delivered in a sequence
as specified by the hierarchy and agreeing on home-
work assignments. Focus turned to relapse prevention
when treatment was approaching termination.
The general non-psychotic psychiatric outpatient
group consisted of patients from a university clinic.
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They received 15 weekly sessions of eclectic psycho-
therapy delivered by graduate psychology students
under supervision by experienced psychologists [24].
The general outpatient group had individual treatment
only. Supervisors had different backgrounds with train-
ing in CBT or psychodynamic therapies. Supervisors
were to ensure that treatment should be based on good
clinical research practice. Choice of treatment was made
in agreement between therapists and supervisors. The
average age in this sample was 34.5 years (SD: 11.4) and
74.5 % (n = 82) were female. Exclusion criteria included
psychosis, violent behaviour, serious substance abuse or
suicidal behaviour. Seven participants from the control
group were excluded from our analyses due to being di-
agnosed with OCD. Participants in the non-psychotic
control group were diagnosed using Mini International
Neuropsychiatric Interview (MINI) [25], by graduate
students under supervision and observation by experi-
enced clinical psychologists.
The psychiatric control group presented with a variety
of different problems:; one with pathological gambling;
two with anorexia; three with somatoform disorder;
three with hypochondriasis; six with adjustment dis-
order; one with post-traumatic stress disorder; six with
mixed anxiety and depression; nine with generalized
anxiety disorder; 11 with panic disorder/agoraphobia;
one with specific phobia; 14 with social phobia; 36 with
depressive disorders; one with bipolar disorder; one with
cannabis related disorders, and 10 people were diagnosed
with a personality disorder (in some cases the graduate
students did SCID-II interviews in addition to the MINI).
The number of patients assessed with SCID-II is un-
known. SCID-II was not used as a routine procedure, but
administered when the therapist had a hypothesis that the
patient suffered from a personality disorder. Twenty par-
ticipants in the non-psychotic psychiatry control group
were not diagnosed with a specific disorder. They were
still included in the study as they were treatment seeking
and received treatment at the clinic.
For the non-psychotic control group, a one-way
ANOVA revealed no significant difference between five
different diagnostic groups with regard to scores on
psychoticism, F(4,102) = 2.113, p = .085, or paranoid
ideation, F(4, 102) = 2.148, p = .08. Post-hoc tests using
Tukey’s method revealed that the no diagnosis group
trended towards lower scores than the depression
group on paranoid ideation (p = .078) and psychoticism
(p = .117). The five diagnostic groups consisted of; depres-
sive disorders (n = 28), anxiety disorders (n = 39), person-
ality disorders (n = 8), several comorbid disorders (n = 12),
and no diagnosis (n = 20).
The non-psychotic OCD group and the non-psychotic
psychiatric control group had comparable demographic
characteristics. There were no significant difference
between the two groups with regard to age, t(234) = .22,
p = .83, and gender, F(1, 241) = .29, p = .59. The two
groups were also comparable with regard to employment
status. A considerable proportion of the patients were
unemployed or receiving disability benefits as 47.3 % of
the psychiatric controls and 48.3 % of the OCD patients
were not working or studying. The study was approved
by Regional Committee for Medical and Health Research
Ethics in Norway. Written consent for participation in
the study was obtained from participants.
Assessments
Symptom Checklist 90 Revised (SCL-90-R)
Psychotic- and schizotypal symptoms were measured
with the subscales psychoticism (example item; “The idea
that something is wrong with your mind”) and paranoid
ideation (example item; “Feeling that you are watched or
talked about by others”) of SCL-90-R [26]. The SCL-90-
R consists of ninety questions that can be answered on a
scale from zero (not at all) to four (extremely). It mea-
sures symptoms from the past week. Its factor structure
and generalizability has been debated [27], and it has
been suggested that the SCL-90-R is a measure of nega-
tive affect rather than nine different symptom clusters.
Nevertheless, a study has shown that the two subscales
psychoticism and paranoid ideation can discriminate
patients with psychotic disorder or psychotic symptoms
from patients with non-psychotic disorder or psychosis
in remission [28]. Furthermore, these subscales, and
new subscales consisting of questions from both sub-
scales, have been utilized as measures of both subclin-
ical psychotic and schizotypal symptoms in several
studies [15, 29–34].
Two different subscales have been suggested to measure
psychotic and schizotypal symptoms using the SCL-90
[33]. The first was labelled schizotypal signs (example item;
“Feeling others are to blame for most of your troubles”)
since it resembled criteria for schizotypal personality dis-
order, whereas the second was labelled schizophrenia nu-
clear symptoms (example item; “Hearing voices that other
people do not hear”) due to its similarities with criteria for
schizophrenia. Later studies have validated these two
subscales [15, 32] and they are assumed to represent
psychotic and schizotypal symptoms in a more adequate
and stable manner than the two previously used subscales.
They have also been used in meta-studies on psychotic ex-
periences in the normal population [29]. In the current
study, both the two original subscales and the two scales
suggested by Rössler and colleagues were used.
Yale-Brown Obsessive Compulsive Scale (Y-BOCS)
Y-BOCS [35] was utilized to measure symptoms of OCD.
Y-BOCS is considered the gold standard for measuring
OCD severity. Obsessions and compulsions are rated on a
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0–4 scale with regard to frequency, distress, interference,
resistance, and control. Only the OCD group was assessed
using Y-BOCS.
Beck Depression Inventory (BDI)
BDI [36] is one of the most widely used instruments for
identification and severity measurement of depressive
symptoms. In the current study BDI was employed as a
control variable as several authors have argued that de-
pressive symptoms might bias self-rated psychotic




As expected, the non-psychotic OCD group (M = 2.02,
SD = .84) had significantly higher scores than the non-
psychotic control group (M = 1.32, SD = .69) on the
OCD scale of the SCL-90, t(241) = 6.918, p = .000. There
were no differences between the two groups on the depres-
sion scale of SCL-90 (1.52 [.87] for the non-psychotic OCD
group vs. 1.62 [.81] for the non-psychotic psychiatric
controls, t(241) = −.88, p = .38). Also, there were no dif-
ferences between the samples on the total score of
SCL-90 (1.17 [.68] for the non-psychotic OCD group
vs. 1.10 [.58] for the non-psychotic psychiatric controls),
t(241) = .82, p = .41.
Psychotic- and schizotypal symptoms
Independent t-tests comparing the two groups at pre-
and post-treatment found no significant differences
between them with regard to psychoticism, paranoid
ideation signs, schizophrenia nuclear symptoms, or schizo-
typal signs. As presented in Table 1, the non-psychotic
OCD group and the non-psychotic general patient group
were very similar both before and after treatment concern-
ing psychotic- and schizotypal symptoms. Lowest scores
were obtained on the schizophrenia nuclear symptoms
(mean item score of .18 for both groups on a scale of 0–4),
while mean item scores of psychoticism was approximately
.50 for both groups. Scores on paranoid ideating and
schizotypal signs were approximately .80 for both groups.
For the schizophrenia nuclear symptoms, 34.8 % of the
OCD group had a confirming score of 1 or more com-
pared to 34.5 % for the control group. This similarity was
evident for the other subscales as well; for psychoticism,
88 % of the non-psychotic OCD group had a confirming
score compared to 88.2 % in the non-psychotic controls.
For paranoid ideation, 90.2 % in the non-psychotic OCD
group had a confirming score compared with 85.5 % in
the non-psychotic controls. And for schizotypal signs,
94 % in the non-psychotic OCD group had a confirming
score compared with 90.9 % of the non-psychotic controls.
There was great variation within each scale. Concerning
psychotic symptoms, items such as hearing voices that
other people do not hear, or the idea that someone else
can control your thoughts, only 2.3 and 6.0 % had a score
higher than zero. Items such as feeling lonely even when
you are with other people and the idea that something is
wrong with your mind was more common; as many as
65.2 and 50 % had scores higher than zero. There was
somewhat less variation within schizotypal scores. One
third reported feeling that others are to blame for most of
your troubles, whereas more than two thirds reported hav-
ing ideas or beliefs that others do not share.
A closer inspection using independent t-tests for the
individual subscale items found four significant differ-
ences between the two patient groups: having thoughts
about sex that bother you a lot (item 84) (p = .000), the
idea that you should be punished for your sins (item 85,
p = .006), and having ideas or beliefs that others do not
share (item 68, p = .000) were more common in the
OCD group. The idea that something serious is wrong
with your body (item 87, p = . 004) was more common
in the control group. Put differently, the observed differ-
ences between the groups appeared more related to
OCD symptoms rather than psychotic symptoms.
Treatment effects
We conducted repeated measures ANOVA comparing
slopes of change for the non-psychotic OCD and control
group. For psychoticism there was a significant reduction
of symptoms, F(1,172) = 33.870, p = .000, η2 = .165, and
no interaction effect F(1,172) = .006, p = .939. There was
not a significant difference in treatment effect between
non-psychotic OCD group and controls for psychoticism,
F(1,172) = .081, p = .611, η2 = .002.
For paranoid ideation signs there was a significant re-
duction of symptoms, F(1,172) = 36.036, p = .000, η2 = .173,
and no interaction effect F(1,172) = .640, p = .425. There
was not a significant difference in treatment effect between
the non-psychotic OCD group and controls for paranoid
ideation signs, F(1,172) = .037, p = .848, η2 = .000.
Table 1 Psychotic- and schizotypal symptoms in OCD group
(n = 103) and outpatient group (n = 71) before and after treatment
OCD GP Sign.
Psychoticism pre-treatment .50 (.49) .54 (.45) .71
Psychoticism post-treatment .34 (.39) .37 (.41) .96
Paranoid ideation pre-treatment .85 (.67) .80 (.69) .29
Paranoid ideation post-treatment .56 (.61) .57 (.61) .85
Schizophrenia nuclear sxs pre-treatment .18 (.32) .18 (.32) .78
Schizophrenia nuclear sxs post-treatment .11 (.24) .12 (.28) .44
Schizotypal signs pre-treatment .87 (.70) .88 (.70) .40
Schizotypal signs post-treatment .59 (.61) .64 (.63) .80
OCD =OCD group, GP = General psychiatric outpatient sample, sxs = symptoms.
Scales range from 0 (not at all) to 4 (extremely)
Solem et al. BMC Psychiatry  (2015) 15:121 Page 4 of 7
For schizophrenia nuclear symptoms there was a signifi-
cant reduction of symptoms, F(1,172) = 6.960, p = .009,
η2 = .039, and no interaction effect F(1,172) = .012, p = .914.
There was not a significant difference in treatment effect
between the non-psychotic OCD group and controls for
schizophrenia nuclear signs, F(1,172) = .032, p = .858,
η2 = .000.
For schizotypal signs there was also a significant reduc-
tion of symptoms, F(1,170) = 36.727, p = .000, η2 = .178,
and no interaction effect F(1,170) = .265, p = .607. Again,
there was not a significant difference in treatment effect
between the non-psychotic OCD group and controls for
schizotypal signs, F(1,170) = .111, p = .739, η2 = .001.
Specificity of psychotic and schizotypal symptoms to OCD
Correlation analyses were conducted to further investi-
gate the possible specificity of psychotic and schizotypal
symptoms to OCD. Partial correlations were also ob-
tained controlling for the possible confounding effects of
depression. The results of this analysis are presented in
Table 2. There were weak but significant correlations be-
tween OCD symptoms and psychotic and schizotypal
symptoms, however, these correlations did not remain
significant when controlling for depressive symptoms. A
previous study [16] found that schizotypal and OCD
symptoms were associated among people reporting se-
vere symptoms. In our study, the correlations were non-
significant when only patients with Y-BOCS scores above
28 (N = 26) were included. In fact the correlations were
negative and ranged from -.14 (psychoticism, p = .48)
to -.36 (schizophrenia nuclear symptoms, p = .07).
A final aim of the study was to explore if psychotic
and schizotypal symptoms affected treatment outcome
for OCD. As evident from Table 2, after controlling for
depressive symptoms, there was no association between
psychotic- or schizotypal symptoms before treatment
and OCD symptoms after treatment. Thus, higher levels
of these symptoms did not attenuate the effect of ERP.
Discussion
Comparison between OCD patients and the general
patient sample indicated that there was no significant
difference in self-reported psychotic- or schizotypal
symptoms. Compared with previous research using
healthy controls [27], the non-psychotic OCD group
report significantly more psychotic- and schizotypal
signs (equal to an effect size of .92 for both scales).
The fact that the non-psychotic OCD group and the
general patient group resemble each other indicates
that such symptoms constitute a general tendency for
all psychiatric morbidity and not specifically for OCD.
However, this study did not include psychotic patients,
and it is therefore possible that OCD patients more
often display psychotic comorbidity than other patient
groups, but that the exclusion of such patients in the
current study did not reveal such a tendency. It is,
nevertheless, interesting that among non-psychotic
OCD-patients, psychotic- and schizotypal symptoms
were related to depressive symptoms, and not OCD
symptoms. Scores on psychotic and schizotypal symp-
toms were moderately correlated with depressive
symptoms. There may be considerable overlap between
depressive symptoms and some of the SCL-90-R items
assessing psychotic and schizotypal symptoms. This corre-
sponds with previous research which has challenged the
factor structure of the SCL-90-R. Vassend and Skrondal
[27] found psychotic and schizotypal symptoms to be sig-
nificantly associated with the other symptom dimensions
and it was suggested that SCL-90-R may measure general
negative affectivity rather than specific symptom dimen-
sions [27]. A previous study [4] found an association be-
tween OCD symptoms and psychotic symptoms after
Table 2 Correlations between symptoms of OCD, psychotic symptoms, and depression in the OCD group
Y-BOCS pre Y-BOCS post BDI pre BDI post
α Bivariate Partial Bivariate Partial Bivariate Partial Bivariate Partial
Psychotisism pre-treatment .77 .25** .05 .17 -.14 .55** .50** .58** .51**
Psychotisism post-treatment .70 .21* .32** .16 .40** .36** .61** .56**
Paranoid ideation pre-treatment .75 .23* .05 .16 -.16 .52** .48** .54** .50**
Paranoid ideation post-treatment .75 .20* .34** .19 .35** .31** .59** .55**
Schizotypal signs pre-treatment .83 .26** .06 .19* -.15 .57** .52** .58** .53**
Schizotypal signs post-treatment .80 .22* .35** .19 .41** .37** .67** .63**
Sch. nuclear sxs pre-treatment .41 .02 .04 .04 .08 .23** .23** .19* .11
Sch. nuclear sxs post-treatment .04 .08 .16 .11 .13 .11 .20* .16
BDI pre .92 .41** .14 .60**
BDI post .14 .40**
Pre = pre-treatment, Post = post-treatment, BDI = Beck Depression Inventory, Y-BOCS = Yale-Brown Obsessive Compulsive Scale, Sch. Nuclear sxs = schizophrenia
nuclear symptoms. Partial correlations control for BDI/Y-BOCS. *p < .05, **p < .01
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controlling for several variables, including depression.
Their study did however, not exclude psychotic patients
and had a smaller sample of subjects diagnosed with
OCD. The lack of such an association in the present study
may stem from the fact that OCD symptoms and schizo-
typal symptoms associate at only high levels of both symp-
toms [16], and that the overall level of psychotic- and
schizotypal symptoms were too low. However we did not
find evidence of such when investigating the patients with
the most severe OCD symptoms.
In the non-psychotic OCD group, only 6 % reported
thought control (the idea that someone else can control
your thoughts) and 2 % hearing voices. Other psychotic
and schizotypal symptoms were much more prevalent.
Such great variation should be expected considering the
heterogeneity of psychotic symptoms. In a study by
Adam et al. [9] nearly 40 % of 30 OCD patients reported
hallucinations or delusions. Differences between these
findings and the present study may be due to the exclu-
sion of patients diagnosed with comorbid psychotic disor-
ders. Additionally, the current study assessed symptoms
over the past week, whereas the Adam et al. study [9]
assessed symptoms in the past twelve months.
The presence of psychotic- and schizotypal symptoms
was not associated with reduced response to OCD treat-
ment. Previous studies have found that OCD patients
with comorbid schizotypal disorder do not respond as
well to ERP [3]. The results from our study, however,
suggest that non-psychotic OCD patients with sub-
clinical levels of schizotypal disorder or psychotic dis-
order do not require additional therapeutic interventions
beyond standard ERP. However, it was observed that pa-
tients with the highest load of schizotypal symptoms had
significantly greater depressive symptomatology post-
treatment. This may indicate that additional therapeutic
intervention for depressive symptoms may be warranted
for this subgroup of OCD patients.
A significant reduction in both psychotic- and schizo-
typal symptoms was observed following treatment and the
reductions were similar for the non-psychotic OCD group
and the control group. This indicates that ERP also has
therapeutic efficacy for psychotic and schizotypal symp-
toms. Such improvement may be of great importance con-
sidering the finding that psychotic symptoms in OCD may
increase risk for developing psychotic disorder [4].
The current study has different strengths and limita-
tions. A relatively large size of patients has been examined
and contrary to several previous studies, we controlled for
depressive symptoms. Limitations include the use of SCL-
90-R as the only measure of psychotic or schizotypal
symptoms. The validity of the SCL-90-R in assessing
schizotypal symptoms in OCD is unclear. Even trained as-
sessors may experience trouble with classifying particular
complaints as a symptom of OCD or psychosis. Thus, it
seems likely that patients might have difficulties with
responding to self-report questionnaires assessing such
symptoms. Future research should explore in greater
depth the reliability of self-reported psychotic symptoms;
although some studies have provided preliminary evidence
of reliability and validity [28]. Future research should also
explore the relationship between poor insight and psych-
otic symptoms in OCD. Another limitation is the use of a
general psychiatric outpatient sample instead of sub-
samples of different specific diagnostic groups. There is a
possibility that psychotic and schizotypal symptoms differ
across disorders. We did not find any evidence of such dif-
ferences within our non-psychotic control group, but that
could be due to small sample sizes. A final limitation con-
cerns the different methods for determining diagnoses
across the samples.
Conclusions
The presence of self-reported psychotic- and schizotypal
symptoms are similar among non-psychotic OCD patients
and general non-psychotic psychiatric outpatients. Such
symptoms were associated with depressive symptoms
rather than OCD symptoms. Sub-diagnostic levels of
such symptoms are not associated with reduced treatment
response to ERP, in fact ERP is associated with a reduction
in both psychotic- and schizotypal symptoms. The reduc-
tions in these symptoms were similar for ERP for OCD
and for eclectic treatment for psychiatric outpatients.
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